13G

Company

Sarepta Therapeutics, Inc.

Filed

November 17, 1998

Accession Number

0001047469-98-041456

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →